Terms: = Uterine cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591
72 results:
1. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
Zhang Y; Li L; Han Q; Wen L
J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
[TBL] [Abstract] [Full Text] [Related]
2. Factors associated with the persistence of human papillomavirus after surgery in patients with cervical cancer.
Wang Q; Zhou FY; Ding JX
Diagn Microbiol Infect Dis; 2024 Apr; 108(4):116201. PubMed ID: 38340484
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of the efficacy of 5% versus 8% acetic acid concentrations for detecting premalignant and malignant lesions in colposcopy.
Yilmaz A; Gulbahar A; Sen S
Medicine (Baltimore); 2023 Dec; 102(50):e36341. PubMed ID: 38115367
[TBL] [Abstract] [Full Text] [Related]
4. Modifiable prognostic factors in uterine fibroid development: a systematic review of literature.
Keizer AL; Semmler A; Kok HS; van Kesteren PJM; Huirne JAF; Hehenkamp WJK
J Obstet Gynaecol; 2024 Dec; 44(1):2288225. PubMed ID: 38102975
[TBL] [Abstract] [Full Text] [Related]
5. Impact of cervical screening by human papillomavirus genotype: Population-based estimations.
Wang J; Elfström KM; Lagheden C; Eklund C; Sundström K; Sparén P; Dillner J
PLoS Med; 2023 Oct; 20(10):e1004304. PubMed ID: 37889928
[TBL] [Abstract] [Full Text] [Related]
6. The impact of age-relevant and generic infographics on knowledge, attitudes and intention to attend cervical screening: A randomized controlled trial.
Waite F; Marlow LAV; Nemec M; Waller J
Br J Health Psychol; 2024 Feb; 29(1):204-220. PubMed ID: 37770383
[TBL] [Abstract] [Full Text] [Related]
7. Pattern of infection and genotypes of human papillomavirus in Zhengzhou City based on a four-year (2015-2018) epidemiological study.
Liu J; Wang C; Ma J; Wei S; Li Y; Chen X; Zhao Q; Huo Y
Women Health; 2023; 63(5):383-391. PubMed ID: 37280193
[TBL] [Abstract] [Full Text] [Related]
8. A nomogram for predicting overall survival in patients with type II endometrial carcinoma: a retrospective analysis and multicenter validation study.
Ren X; Wang MM; Wang G; Sun XM; Xia TT; Yao Y; Wang CC; Jiang AF; Wang H; Cao J; Wei YJ; Sun CG
Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):233-247. PubMed ID: 36647873
[TBL] [Abstract] [Full Text] [Related]
9. Reasons that clinicians in Australia offer cervical screening outside guidelines for frequency, age and co-testing.
Dodd RH; Obermair HM; McCaffery KJ
Public Health Res Pract; 2022 Dec; 32(4):. PubMed ID: 36509688
[TBL] [Abstract] [Full Text] [Related]
10. [Preoperative serum creatinine as an independent prognostic biomarker in patients with early-stage cervical adenocarcinoma].
Li N; Chen RZ; Wang FF; Li BH
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):1993-1998. PubMed ID: 35817723
[No Abstract] [Full Text] [Related]
11. Increased mortality and non-cancer morbidity risk may be associated with early menopause and varies with aetiology: An exploratory population-based study using data-linkage.
Thong EP; Hart RJ; Teede HJ; Vincent AJ; Enticott JC
Maturitas; 2022 Oct; 164():60-66. PubMed ID: 35803198
[TBL] [Abstract] [Full Text] [Related]
12. Body Weight Is a Valid Predictor of the Long-Term Prognosis of Cervical cancer.
Lu L; Ji S; Jiang J; Yan Y
Comput Math Methods Med; 2022; 2022():5613350. PubMed ID: 35720030
[TBL] [Abstract] [Full Text] [Related]
13. A comparison of behavioural models explaining cervical cancer screening uptake.
Dsouza JP; Broucke SVD; Pattanshetty S; Dhoore W
BMC Womens Health; 2022 Jun; 22(1):235. PubMed ID: 35710374
[TBL] [Abstract] [Full Text] [Related]
14. Risk Factor and Treatment of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Intraepithelial Neoplasia.
Kim JH; Kim J; Kim K; No JH; Kim YB; Suh DH
J Low Genit Tract Dis; 2022 Apr; 26(2):147-151. PubMed ID: 35238809
[TBL] [Abstract] [Full Text] [Related]
15. Impact of past obstetric history and cervical excision on preterm birth rate.
Collins A; Motiwale T; Barney O; Dudbridge F; McParland PC; Moss EL
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):1995-2002. PubMed ID: 34698370
[TBL] [Abstract] [Full Text] [Related]
16. The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening.
Li B; Guo R; Lai T; Qiao L; Fu H
J Obstet Gynaecol Res; 2021 Aug; 47(8):2720-2728. PubMed ID: 34036681
[TBL] [Abstract] [Full Text] [Related]
17. Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
Pry JM; Manasyan A; Kapambwe S; Taghavi K; Duran-Frigola M; Mwanahamuntu M; Sikazwe I; Matambo J; Mubita J; Lishimpi K; Malama K; Bolton Moore C
Lancet Glob Health; 2021 Jun; 9(6):e832-e840. PubMed ID: 34019837
[TBL] [Abstract] [Full Text] [Related]
18. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis.
Ma X; Liu J; Wang H; Jiang Y; Wan Y; Xia Y; Cheng W
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368784
[TBL] [Abstract] [Full Text] [Related]
19. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
[TBL] [Abstract] [Full Text] [Related]
20. Long non‑coding RNA TP73 antisense RNA 1 facilitates the proliferation and migration of cervical cancer cells via regulating microRNA‑607/cyclin D2.
Zhang H; Xue B; Wang S; Li X; Fan T
Mol Med Rep; 2019 Oct; 20(4):3371-3378. PubMed ID: 31432138
[TBL] [Abstract] [Full Text] [Related]
[Next]
